Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer

Michael A. Gorin, Mark S. Soloway

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Active surveillance with delayed intervention aims to minimize the discomfort, potential complications and costs associated with immediate treatment of recurrent low grade Ta tumors of the bladder. We reviewed the data supporting this management strategy for low risk bladder cancer. Methods: A PubMed® query was performed to identify relevant literature on the topic of active surveillance for low risk bladder cancer. English language publications were reviewed and select data presented. Results: Available data suggest that only 5% to 10% of patients diagnosed with a low grade appearing papillary bladder tumor will have progression in stage or grade. Coupled with the discomfort and potential for complications associated with transurethral resection, this supports the role of active surveillance for patients with small, recurrent, low risk bladder cancer. In addition, this management strategy stands to benefit the health care system by reducing the costs associated with caring for patients with bladder cancer. Conclusions: Active surveillance with delayed intervention represents a safe and cost-effective strategy for patients with recurrent low risk bladder cancer.

Original languageEnglish (US)
Pages (from-to)256-259
Number of pages4
JournalUrology Practice
Volume2
Issue number5
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Costs and Cost Analysis
PubMed
Publications
Language
Delivery of Health Care

Keywords

  • Risk assessment
  • Urinary bladder neoplasms
  • Watchful waiting

ASJC Scopus subject areas

  • Urology

Cite this

Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer. / Gorin, Michael A.; Soloway, Mark S.

In: Urology Practice, Vol. 2, No. 5, 01.09.2015, p. 256-259.

Research output: Contribution to journalArticle

Gorin, Michael A. ; Soloway, Mark S. / Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer. In: Urology Practice. 2015 ; Vol. 2, No. 5. pp. 256-259.
@article{374013c003784c19992747aa21d2f08d,
title = "Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer",
abstract = "Introduction: Active surveillance with delayed intervention aims to minimize the discomfort, potential complications and costs associated with immediate treatment of recurrent low grade Ta tumors of the bladder. We reviewed the data supporting this management strategy for low risk bladder cancer. Methods: A PubMed{\circledR} query was performed to identify relevant literature on the topic of active surveillance for low risk bladder cancer. English language publications were reviewed and select data presented. Results: Available data suggest that only 5{\%} to 10{\%} of patients diagnosed with a low grade appearing papillary bladder tumor will have progression in stage or grade. Coupled with the discomfort and potential for complications associated with transurethral resection, this supports the role of active surveillance for patients with small, recurrent, low risk bladder cancer. In addition, this management strategy stands to benefit the health care system by reducing the costs associated with caring for patients with bladder cancer. Conclusions: Active surveillance with delayed intervention represents a safe and cost-effective strategy for patients with recurrent low risk bladder cancer.",
keywords = "Risk assessment, Urinary bladder neoplasms, Watchful waiting",
author = "Gorin, {Michael A.} and Soloway, {Mark S.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.urpr.2014.12.002",
language = "English (US)",
volume = "2",
pages = "256--259",
journal = "Urology Practice",
issn = "2352-0779",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer

AU - Gorin, Michael A.

AU - Soloway, Mark S.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Introduction: Active surveillance with delayed intervention aims to minimize the discomfort, potential complications and costs associated with immediate treatment of recurrent low grade Ta tumors of the bladder. We reviewed the data supporting this management strategy for low risk bladder cancer. Methods: A PubMed® query was performed to identify relevant literature on the topic of active surveillance for low risk bladder cancer. English language publications were reviewed and select data presented. Results: Available data suggest that only 5% to 10% of patients diagnosed with a low grade appearing papillary bladder tumor will have progression in stage or grade. Coupled with the discomfort and potential for complications associated with transurethral resection, this supports the role of active surveillance for patients with small, recurrent, low risk bladder cancer. In addition, this management strategy stands to benefit the health care system by reducing the costs associated with caring for patients with bladder cancer. Conclusions: Active surveillance with delayed intervention represents a safe and cost-effective strategy for patients with recurrent low risk bladder cancer.

AB - Introduction: Active surveillance with delayed intervention aims to minimize the discomfort, potential complications and costs associated with immediate treatment of recurrent low grade Ta tumors of the bladder. We reviewed the data supporting this management strategy for low risk bladder cancer. Methods: A PubMed® query was performed to identify relevant literature on the topic of active surveillance for low risk bladder cancer. English language publications were reviewed and select data presented. Results: Available data suggest that only 5% to 10% of patients diagnosed with a low grade appearing papillary bladder tumor will have progression in stage or grade. Coupled with the discomfort and potential for complications associated with transurethral resection, this supports the role of active surveillance for patients with small, recurrent, low risk bladder cancer. In addition, this management strategy stands to benefit the health care system by reducing the costs associated with caring for patients with bladder cancer. Conclusions: Active surveillance with delayed intervention represents a safe and cost-effective strategy for patients with recurrent low risk bladder cancer.

KW - Risk assessment

KW - Urinary bladder neoplasms

KW - Watchful waiting

UR - http://www.scopus.com/inward/record.url?scp=84940614763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940614763&partnerID=8YFLogxK

U2 - 10.1016/j.urpr.2014.12.002

DO - 10.1016/j.urpr.2014.12.002

M3 - Article

AN - SCOPUS:84940614763

VL - 2

SP - 256

EP - 259

JO - Urology Practice

JF - Urology Practice

SN - 2352-0779

IS - 5

ER -